TrialESC heart failure2025

Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study.

Christina G Hutten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.